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To the editor
   Sir, swine flu is a problematic emerging viral infection. 
Vaccine is believed to be the best prevention method[1]. 
Nevertheless, effective vaccine is still not available, hence, 
ongoing research for new vaccine for swine flu is useful. 
The presently available vaccine was firstly developed in 
urgent situation to fight “pandemic swine flu”[1] and there 
is no large trial to support its effectiveness. The remained 
questions are also on safety and cost effective. How to 
further improve is the interesting question. In vaccinology, 
epitope finding is the basic step for development of the 
vaccine. Routinely, the T-cell epitope is usually sought 
in order to be the basic data for development of vaccine 
to combat virus infection. However, the role of antibody, 
humoral immunity, should not be forgotten. According to 
the report by Greenbaum et al., it was reported that “only 
31% (8/26) of B-cell epitopes present in recently circulating 
H1N1 strains are conserved in the S-OIV, with only 17% (1/6) 
conserved in the hemagglutinin and neuraminidase surface 
protein[2]” and “69% (54/78) of the epitopes recognized by 
CD8(+) T cells are completely invariant[2].”Greenbaum et al 
concluded that a new vaccine based on the specific S-OIV 
hemagglutinin and neuraminidase proteinswith special 
focus on antibody mediated mechanism would be the 
hope for effective prevention[2]. For swine flu, the T cell 
epitopes have been well described and those epitopes are 
called “swine-origin influenza A H1N1 virus cytotoxic T 
lymphocyte epitope peptides”. Those T cell epitopes are 
accepted for cellular immunity correspondence. But, it is 
still the myth about the humoral immunity correspondence. 
Assessment on B-cell epitope property can lead to the 
answer and this can be done by standard bioinformatics 
investigation. Here, the recorded sequences of swine flu 
T cell epitope peptides in protein database, PubMed are 
used as template and standard bioinformatics 
assessment for B cell epitope property using standard 
referencing methods[3,4] was done. From assessment of 
9 available sequences (from 9 to 275 aa), the best B cell 
epitopes property was “65 RNV KET AQT YGV GLN T” from 
accession: 3QQ4_A GI: 365813033 (score=0.93). The detected 
part of sequence is the part with the most immunogenicity, 
both T cell and B cell immunity correspondence. It can 
be useful basic information for further swine flu vaccine 
development.  
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